Article Abstract

Natriuretic peptide-guided versus clinically guided therapy for chronic heart failure: careful expert clinical management can remove need for biomarker-tailored dosing adjustment

Authors: Renato De Vecchis


This editorial refers to a randomized controlled trial (RCT), namely the Guided Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) study conducted by Felker and colleagues, whose results have been recently published (1).